Your session is about to expire
← Back to Search
Behavioural Intervention
BASIS-T Strategy for Childhood Behavior Challenges (BASIS-T Trial)
N/A
Recruiting
Led By Aaron Lyon, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up beginning of school year, mid-school year, end of school year
Summary
This trial will test a new strategy to help educators implement evidence-based practices to reduce social, emotional, and behavioral challenges in kids. This strategy focuses on motivating and influencing educators to help kids.
Who is the study for?
This trial is for K-5th grade teachers at elementary or K-8 schools who haven't been trained or supervised in Positive Greetings at the Door (PGD) in the past 5 years. Special education-only classroom teachers are not eligible.
What is being tested?
The BASIS-T efficacy trial is testing a strategy called BASIS-T, designed to help teachers adopt and implement school-based practices to improve student social, emotional, and behavioral outcomes. It's compared with an Attention Control group.
What are the potential side effects?
Since this trial involves educational strategies rather than medical interventions, it does not have side effects in the traditional sense. However, there may be varying impacts on teacher workload and stress.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ beginning of school year, mid-school year, end of school year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~beginning of school year, mid-school year, end of school year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Implementation Outcome: Adoption
Implementation Outcome: Fidelity and Sustainment - Observed
Implementation Outcome: Fidelity and Sustainment - Self Report
+5 moreSecondary study objectives
Student Behavioral Outcomes
Student Educational Outcomes
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BASIS-TExperimental Treatment1 Intervention
BASIS-T is designed to address the behavioral components often missing from standard EBPP training and consultation that relate to motivation prior to receiving EBPP training, and volition after EBPP training. It is an EBPP-agnostic implementation strategy designed to be delivered within the Preparation/Adoption phase, immediately prior to Active Implementation (CITE EPIS). BASIS-T targets behavioral intentions via improvement in attitudes, subjective norms, and self-efficacy.
Group II: Attention ControlPlacebo Group1 Intervention
Teachers assigned to the ACC will receive pre- and post-training experiences designed to mirror those received in the BASIS-T condition. These training experiences will be virtual, delivered by the same interventionist, and be approximately the same length as the BASIS-T experiences, but will not contain any of the BASIS-T content or mechanisms of change. The ACC pre-training experience will define, describe, and advocate for EBP implementation in schools. Content will be didactic, as is typical in professional development training for teachers.
Find a Location
Who is running the clinical trial?
Institute of Education SciencesFED
8 Previous Clinical Trials
2,936 Total Patients Enrolled
University of WashingtonLead Sponsor
1,831 Previous Clinical Trials
1,907,293 Total Patients Enrolled
Aaron Lyon, PhDPrincipal InvestigatorUniversity of Washington
5 Previous Clinical Trials
874 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a teacher for grades K-5 in a regular classroom, not special education.I have been trained or supervised in PGD within the last 5 years.
Research Study Groups:
This trial has the following groups:- Group 1: BASIS-T
- Group 2: Attention Control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.